Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
anticonvulsants
anticonvulsants, absorption
anticonvulsants, bioavailability
anticonvulsants, blood level determination of
anticonvulsants, brand name
anticonvulsants, compliance
anticonvulsants, effectiveness
anticonvulsants, generic
anticonvulsants, pharmacokinetics
anticonvulsants, selection of
anticonvulsants, teratogenicity of
anticonvulsants, untoward effects of
behavioral disorder
brand name drug
carbamazepine
carbamazepine, toxicity
chest pain
children
complications
contraindications
controversies in neurology
cost
cost effectiveness
diabetes insipidus
dilantin
dilantin, serum level
drug interactions
drug of choice
efficacy
enzyme, induction
erythema multiforme
ethics in neurology
flushing
generic drugs
hospital length of stay
hospitalization
iatrogenic neurologic disorders
lamotrigine
manic-depressive
medical-legal aspects of neurology
migraine
migraine, treatment of
movement disorder
movement disorder, treatment of
mylan
mysoline
neck pain
pain
pain, central
pain, management of chronic
paresthesias
personality disorder
phantom limb
phenobarbital
practice guidelines
pregnancy, neurologic complications in
quality of care
quality of life
rash
recurrent
review article
risk factors
safety
seizure
seizure, breakthrough
seizure, recurrent
seizure, treatment of
sodium valproate
sumatriptan
teratogenesis
teratogenic drugs
topiramate
trauma
treatment of neurologic disorder
trigeminal neuralgia
trigeminal neuralgia, treatment of
triptans
Showing articles 0 to 50 of 6682 Next >>

Switching the Manufacturer of Antiepileptic Drugs is Associated with Higher Risk of Seizures: A Nationwide Study of Prescription Data in Germany
Ann Neurol 84:918-925, Lang, J.D.,et al, 2018

Antiseizure Medications
Neurol 86:e187-e188, Karceski, S., 2016

Assessing Bioequivalence of Generic Antiepilepsy Drugs
Ann Neurol 70:221-228,192, Krauss, G.L.,et al, 2011

Generic Antiepileptic Drugs and Associated Medical Resource Utilization in the United States
Neurol 74:1566-1574, 1562, Labiner,D.M., et al, 2010

Triptan Therapy in Migraine
NEJM 363:63-70, Loder,E., 2010

The Value of Specifying Brand-Name Antiepileptic Drugs
Arch Neurol 66:1415-1416, 1418, Ng,Y., 2009

Generic Anticonvulsant Use in Children: Do We Have Evidence to Recommend Brand Formulations?
Arch Neurol 66:1417-1418, Hamiwka,L., 2009

The Risks and Costs of Multiple-Generic Substitution of Topiramate
Neurol 72:2122-2129, Duh,M.S.,et al, 2009

Clinical Consequences of Generic Substitution of Lamotrigine for Patients with Epilepsy
Neurol 70:2179-2186, LeLorier,J.,et al, 2008

Generic Substitution in the Treatment of Epilepsy: Case Evidence of Breakthrough Seizures
Neurol 71:525-530, Berg,M.J.,et al., 2008

Position Statement on the Coverage of Anticonvulsant Drugs for the Treatment of Epilepsy
Neurol 68:1249-1250,1245, Liow,K.,et al, 2007

Lower Phenytoin Serum Levels in Persons Switched from Brand to Generic Phenytoin
Neurol 63:1494-1496, Burkhardt,R.T.,et al, 2004

Effect of Food on Absorption of Dilantin Kapseals and Mylan Extended Phenytoin Sodium Capsules
Neurol 57 582-589,571, Wilder,B.J.,et al, 2001

Carbamazepine Toxicity Resulting from Generic Substitution
Neurol 43:2696-2697, 24351993., Gilman,J.T.,et al, 1993

Therapeutic Bioequivalency Study of Brand Name Versus Generic Carbamazepine
Neurol 42:1147-1153, Oles,K.S.,et al, 1992

New Uses and Old for Carbamazepine
Patient Care 24:48-81, Browne,T.R.,et al, 1990

Assessment:Generic Substitution for Antiepileptic Medication
Report of Therap & Tech Assess Subcomm, Neurol 40:1641-164390., , 1990

Generic Substitutions for Antiepileptic Drugs
Neurol 40:1647-1651, Nuwer,M.R.,et al, 1990

Generic Carbamazepine and Erythema Multiforme:Generic-Drug Nonequivalency
NEJM 321:692-693, Busch,R.L., 1989

Increased Seizure Frequency with Generic Primidone
JAMA 258:1216-1217, Wyllie,E.,et al, 1987

Breakthrough Seizure Following Substitution of Depakene Capsules with a Generic Product
Neurol 37:1885, MacDonald,J.T., 1987

Confused About Confusion
NEJM 386:80-87, Spanjaart, A.M.,et al, 2022

Clinicopathologic Conference, Borrelia Miyamotoi Infection
NEJM 383:1578-1586, Case 32-2020, 2020

Migraine
NEJM 377:553-561, Charles, A., 2017

Non-Alzheimers Dementia 1 Frontotemporal Dementia
Lancet 386:1672-1682, Bang, Jee.,et al, 2015

Clinicopath Conf, Neuro-Behcets Disease
NEJM 360:2341-2351, Case 17-2009, 2009

Transient Encephalopathy after Paclitaxel (Taxol) Infusion
Neurol 46:1596-1599, Perry,J.R.&Warner,E., 1996

Clinicopath. Conference
Pick's Disease of Brain, with Frontal Lobar Atrophy, Degen of Basal Ganglia, Case 16-1986, NEJM 314:, 101-,1986., 1986

Addressing Systemic Complications of Acute Stroke: A Scientific Statement From the American Heart Association
Stroke 56:e15-e29, Kumar,S.,et al, 2025

Spectrum of Intracranial Hemorrhages in Cerebral Venous Thrombosis, A Pictorial Case Series and Review of Pathophysiology and Management
Neurologist 30:45-51, Jha,S.,et al, 2025

Angioedema Following Tenecteplase for Acute Ischemic Stroke
Stroke 55:e242-e244, Dellabella,A., 2024

Clinicopathologic Conference, Brain Abscess Due to Infection with Listeria Monocytogeneses
NEJM 391:1529-1538, Case 33-2024, 2024

Acute Postradiation Lumbosacral Plexopathy
Neurol 103:e209972, Koropouli,E.,et al, 2024

Cerebrovascular Events in Patients Undergoing Transcatheter Aortic Valve Replacement:A Review
Stroke 55:2754-2764, Patel,K.P.,et al, 2024

Optimal Timing of Anticoagulation after Acute Ischaemic Stroke with Atrial Fibrillation (OPTIMAS): A Multicentre, Blinded-Endpoint, Phase 4, Randomised Controlled Trial
Lancet 404:1731-1741, Werring,D.J.,et al, 2024

Intramedullary Spinal Cord Abscess Caused by Acupuncture
Ann Neurol 96:1026-1027, Liu,J.,et al, 2024

Clinical Features, Diagnosis and Management of Klinefelter Syndrome
www.UptoDaate.com, Matsumoto,A.M. & Anawals,B.D., 2024

Middle Meningeal Artery Embolisation for Nonacute Subdural Hematoma
NEJM 391:1901-1912, Ni,J.L.W.,et al, 2024

Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma
NEJM 391:1890-1900, Davies,J.M.,et al, 2024

Chronic Immunotherapy for Myasthenia Gravis
www.UptoDate.Com, Bird,S.J., 2024

Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine, A Phase 4, Randomized, Placebo-Controlled Trial
JAMA Neurol 81:1140-1149, Tepper,S.J.,et al, 2024

Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation
JAMA Neurol 81:1150-1158, Maarse,M.,et al, 2024

How Patients Are Using AI
BMJ 387:q2393, Stokel-Walker,C., 2024

2024 Guide for the Primary Prevention of Stroke:A Guideline From the American Heart Association/American Stroke Association
Stroke 55:e344-e424, Bushnell,C.,et al, 2024

Tranexamic Acid Within 4.5 Hours of Intracerebral Hemorrhage With the CTA Spot Sign, Systematic Review and Individual Patient Meta-Analysis
Neurol 103:e210104, Yassi,N.,et al, 2024

Safety and Efficacy of Staged, Bilateral Focused Ultrasound Thalamotomy in Essential Tremor, An Open-Label Clinical Trial
JAMA Neurol 81:939-946, Kaplitt,M.G.,et al, 2024

Miyazaki Syndrome as a Complication of Shunt Drainage
Ann Neurol 96:1230-1231, vanLanen,R.H.G.J., et al, 2024

Clinicopathologic Conference, Cryptococcal Meningoencephalitis
NEJM 391:2361-2369, Case 40-2024, 2024

Effect of IV Thrombolysis With Alteplase in Patients with Vessel Occlusion in the WAKE-UP Trial
Neurol 104:e209871, Galinovic,I.,et al, 2024



Showing articles 0 to 50 of 6682 Next >>